Authors:
SZYMANSKI S
LIEBERMAN J
POLLACK S
KANE JM
SAFFERMAN A
MUNNE R
UMBRICHT D
WOERNER M
MASIAR S
KRONIG M
Citation: S. Szymanski et al., GENDER DIFFERENCES IN NEUROLEPTIC NONRESPONSIVE CLOZAPINE-TREATED SCHIZOPHRENICS, Biological psychiatry, 39(4), 1996, pp. 249-254
Citation: S. Pollack, DETOURS ON THE ROAD TO AUTONOMY - A CRITIQUE OF THE NEW-YORK-STATE DO-NOT-RESUSCITATE LAW, Archives of internal medicine, 156(13), 1996, pp. 1369-1371
Authors:
SARAVAY SM
POLLACK S
STEINBERG MD
WEINSCHEL B
HABERT M
Citation: Sm. Saravay et al., 4-YEAR FOLLOW-UP OF THE INFLUENCE OF PSYCHOLOGICAL COMORBIDITY ON MEDICAL REHOSPITALIZATION, The American journal of psychiatry, 153(3), 1996, pp. 397-403
Authors:
UMBRICHT D
NOVAK G
BILDER R
JAVITT D
POLLACK S
LIEBERMAN J
KANE J
Citation: D. Umbricht et al., MISMATCH NEGATIVITY, NEUROPSYCHOLOGICAL DEFICITS AND PSYCHOPATHOLOGY IN CHRONIC-SCHIZOPHRENIA, Schizophrenia research, 15(1-2), 1995, pp. 187-188
Authors:
STRICHMANALMASHANU L
WELTFRIEND S
GIDEONI O
FRIEDMANBIRNBAUM R
POLLACK S
Citation: L. Strichmanalmashanu et al., NO SIGNIFICANT ASSOCIATION BETWEEN HLA ANTIGENS AND CLASSIC KAPOSI-SARCOMA - MOLECULAR ANALYSIS OF 49 JEWISH PATIENTS, Journal of clinical immunology, 15(4), 1995, pp. 205-209
Authors:
POLLACK S
LIEBERMAN JA
FLEISCHHACKER WW
BORENSTEIN M
SAFFERMAN AZ
HUMMER M
KURZ M
Citation: S. Pollack et al., A COMPARISON OF EUROPEAN AND AMERICAN DOSING REGIMENS OF SCHIZOPHRENIC-PATIENTS ON CLOZAPINE - EFFICACY AND SIDE-EFFECTS, Psychopharmacology bulletin, 31(2), 1995, pp. 315-320
Authors:
POHFITZPATRICK M
HUANG J
ZAIDER E
WANG X
ROTH P
GARCIA O
POLLACK S
PIOMELLI S
Citation: M. Pohfitzpatrick et al., CONGENITAL ERYTHROPOIETIC PORPHYRIA - BIOCHEMICAL, ENZYMATIC, AND MOLECULAR-GENETIC CHARACTERISTICS OF A SEVERE PHENOTYPE, Journal of investigative dermatology, 104(4), 1995, pp. 602-602
Authors:
SZYMANSKI S
LIEBERMAN J
POLLACK S
SAFFERMAN A
MUNNE R
UMBRICHT D
KANE J
KRONIG M
CHAKOS M
COOPER T
Citation: S. Szymanski et al., CLOZAPINE EFFECTS ON NEUROENDOCRINE RESPONSE TO APOMORPHINE CHALLENGETESTING IN CHRONIC NEUROLEPTIC NONRESPONSIVE SCHIZOPHRENIA - PRELIMINARY FINDINGS, Biological psychiatry, 37(1), 1995, pp. 52-55
Authors:
KRONIG MH
MUNNE RA
SZYMANSKI S
SAFFERMAN AZ
POLLACK S
COOPER T
KANE JM
LIEBERMAN JA
Citation: Mh. Kronig et al., PLASMA CLOZAPINE LEVELS AND CLINICAL-RESPONSE FOR TREATMENT-REFRACTORY SCHIZOPHRENIC-PATIENTS, The American journal of psychiatry, 152(2), 1995, pp. 179-182
Authors:
UMBRICHT D
DEGREEF G
BARR WB
LIEBERMAN JA
POLLACK S
SCHAUL N
Citation: D. Umbricht et al., POSTICTAL AND CHRONIC PSYCHOSES IN PATIENTS WITH TEMPORAL-LOBE EPILEPSY, The American journal of psychiatry, 152(2), 1995, pp. 224-231
Authors:
POLLACK S
BENPORATH E
FUAD B
RAZ R
ETZIONI A
Citation: S. Pollack et al., EPIDEMIOLOGIC AND SEROLOGICAL STUDIES IN HIV-INFECTED ETHIOPIAN IMMIGRANTS TO ISRAEL, Acta paediatrica, 83, 1994, pp. 19-21
Citation: A. Roy et S. Pollack, ARE CEREBROSPINAL-FLUID OR URINARY MONOAMINE METABOLITE MEASURES STRONGER CORRELATES OF SUICIDAL-BEHAVIOR IN DEPRESSION, Neuropsychobiology, 29(4), 1994, pp. 164-167
Citation: Ld. Martin et al., DNA-SEQUENCE REQUIREMENTS FOR THE REGULATION OF IMMOBILIZATION ANTIGEN-A EXPRESSION IN PARAMECIUM-TETRAURELIA, Developmental genetics, 15(5), 1994, pp. 443-451
Authors:
FLEISCHHACKER WW
HUMMER M
KURZ M
KURZTHALER I
LIEBERMAN JA
POLLACK S
SAFFERMAN AZ
KANE JM
Citation: Ww. Fleischhacker et al., CLOZAPINE DOSE IN THE UNITED-STATES AND EUROPE - IMPLICATIONS FOR THERAPEUTIC AND ADVERSE-EFFECTS, The Journal of clinical psychiatry, 55(9), 1994, pp. 78-81